As of May 18
| -0.09 / -1.38%|
The 4 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +47.29% increase from the last price of 6.45.
The current consensus among 5 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.